The pharmaceutical industry develops, produces, and markets drugs or pharmaceuticals for use as medications. Pharmaceutical companies may deal in generic or brand medications and medical devices. They are subject to a variety of laws and regulations that govern the patenting, testing, safety, efficacy and marketing of drugs. The guidelines developed by WHO are prepared through a vast global consultative process involving WHO Member States, national authorities and international agencies; in consultation with the WHO Expert Advisory Panel on the International Pharmacopoeia and Pharmaceutical Preparations, with specialists from industry, national institutions, nongovernmental organizations, etc. The draft guidelines are evaluated during the meetings of the WHO Expert Committee on Specifications for Pharmaceutical Preparations and, if found suitable, adopted as international standards.
Related Journals of Pharmaceutical companies and regulatory guidelines
Asian Journal of Pharmaceutical Technology and Innovation, Internationsl Journal of Drug Regulatory Affairs
Mini Review: Pharmaceutical Regulatory Affairs: Open Access, 2023: 371
Mini Review: Pharmaceutical Regulatory Affairs: Open Access, 2023: 371
Mini Review: Pharmaceutical Regulatory Affairs: Open Access, 2023: 370
Mini Review: Pharmaceutical Regulatory Affairs: Open Access, 2023: 370
Mini Review: Pharmaceutical Regulatory Affairs: Open Access, 2023: 369
Mini Review: Pharmaceutical Regulatory Affairs: Open Access, 2023: 369
Mini Review: Pharmaceutical Regulatory Affairs: Open Access, 2023: 368
Mini Review: Pharmaceutical Regulatory Affairs: Open Access, 2023: 368
Mini Review: Pharmaceutical Regulatory Affairs: Open Access, 2023: 361
Mini Review: Pharmaceutical Regulatory Affairs: Open Access, 2023: 361
Mini Review: Pharmaceutical Regulatory Affairs: Open Access, 2023: 360
Mini Review: Pharmaceutical Regulatory Affairs: Open Access, 2023: 360
Perspective: Pharmaceutical Regulatory Affairs: Open Access, 2023: 367
Perspective: Pharmaceutical Regulatory Affairs: Open Access, 2023: 367
Opinion: Pharmaceutical Regulatory Affairs: Open Access, 2023: 366
Opinion: Pharmaceutical Regulatory Affairs: Open Access, 2023: 366
Brief Report: Pharmaceutical Regulatory Affairs: Open Access, 2023: 365
Brief Report: Pharmaceutical Regulatory Affairs: Open Access, 2023: 365
Short Communication: Pharmaceutical Regulatory Affairs: Open Access, 2023: 364
Short Communication: Pharmaceutical Regulatory Affairs: Open Access, 2023: 364
Commentary: Pharmaceutical Regulatory Affairs: Open Access, 2023: 363
Commentary: Pharmaceutical Regulatory Affairs: Open Access, 2023: 363
Posters & Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Posters & Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Posters & Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Posters & Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Scientific Tracks Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Scientific Tracks Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Posters & Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Posters & Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Pharmaceutical Regulatory Affairs: Open Access received 533 citations as per Google Scholar report